Global Point-of-care Infectious Disease Diagnostics Market Insights, Forecast to 2031.pdf

Report ID: 1664780 | Published Date: Jan 2026 | No. of Page: 111 | Base Year: 2025 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 HIV POC
        1.2.3 Clostridium Difficile POC
        1.2.4 HBV POC
        1.2.5 Respiratory Syncytial Virus POC
        1.2.6 HPV POC
        1.2.7 Influenza/Flu POC
        1.2.8 HCV POC
        1.2.9 MRSA POC
        1.2.10 TB and Drug-Resistant TB POC
    1.3 Market by Application
        1.3.1 Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Home
        1.3.5 Assisted Living Healthcare Facilities
        1.3.6 Laboratories
        1.3.7 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Point-of-care Infectious Disease Diagnostics Market Perspective (2017-2028)
    2.2 Point-of-care Infectious Disease Diagnostics Growth Trends by Region
        2.2.1 Point-of-care Infectious Disease Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Point-of-care Infectious Disease Diagnostics Historic Market Size by Region (2017-2022)
        2.2.3 Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Region (2023-2028)
    2.3 Point-of-care Infectious Disease Diagnostics Market Dynamics
        2.3.1 Point-of-care Infectious Disease Diagnostics Industry Trends
        2.3.2 Point-of-care Infectious Disease Diagnostics Market Drivers
        2.3.3 Point-of-care Infectious Disease Diagnostics Market Challenges
        2.3.4 Point-of-care Infectious Disease Diagnostics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Point-of-care Infectious Disease Diagnostics Players by Revenue
        3.1.1 Global Top Point-of-care Infectious Disease Diagnostics Players by Revenue (2017-2022)
        3.1.2 Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Players (2017-2022)
    3.2 Global Point-of-care Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Point-of-care Infectious Disease Diagnostics Revenue
    3.4 Global Point-of-care Infectious Disease Diagnostics Market Concentration Ratio
        3.4.1 Global Point-of-care Infectious Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Point-of-care Infectious Disease Diagnostics Revenue in 2021
    3.5 Point-of-care Infectious Disease Diagnostics Key Players Head office and Area Served
    3.6 Key Players Point-of-care Infectious Disease Diagnostics Product Solution and Service
    3.7 Date of Enter into Point-of-care Infectious Disease Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Point-of-care Infectious Disease Diagnostics Breakdown Data by Type
    4.1 Global Point-of-care Infectious Disease Diagnostics Historic Market Size by Type (2017-2022)
    4.2 Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Type (2023-2028)
5 Point-of-care Infectious Disease Diagnostics Breakdown Data by Application
    5.1 Global Point-of-care Infectious Disease Diagnostics Historic Market Size by Application (2017-2022)
    5.2 Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Point-of-care Infectious Disease Diagnostics Market Size (2017-2028)
    6.2 North America Point-of-care Infectious Disease Diagnostics Market Size by Type
        6.2.1 North America Point-of-care Infectious Disease Diagnostics Market Size by Type (2017-2022)
        6.2.2 North America Point-of-care Infectious Disease Diagnostics Market Size by Type (2023-2028)
        6.2.3 North America Point-of-care Infectious Disease Diagnostics Market Share by Type (2017-2028)
    6.3 North America Point-of-care Infectious Disease Diagnostics Market Size by Application
        6.3.1 North America Point-of-care Infectious Disease Diagnostics Market Size by Application (2017-2022)
        6.3.2 North America Point-of-care Infectious Disease Diagnostics Market Size by Application (2023-2028)
        6.3.3 North America Point-of-care Infectious Disease Diagnostics Market Share by Application (2017-2028)
    6.4 North America Point-of-care Infectious Disease Diagnostics Market Size by Country
        6.4.1 North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2017-2022)
        6.4.2 North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Point-of-care Infectious Disease Diagnostics Market Size (2017-2028)
    7.2 Europe Point-of-care Infectious Disease Diagnostics Market Size by Type
        7.2.1 Europe Point-of-care Infectious Disease Diagnostics Market Size by Type (2017-2022)
        7.2.2 Europe Point-of-care Infectious Disease Diagnostics Market Size by Type (2023-2028)
        7.2.3 Europe Point-of-care Infectious Disease Diagnostics Market Share by Type (2017-2028)
    7.3 Europe Point-of-care Infectious Disease Diagnostics Market Size by Application
        7.3.1 Europe Point-of-care Infectious Disease Diagnostics Market Size by Application (2017-2022)
        7.3.2 Europe Point-of-care Infectious Disease Diagnostics Market Size by Application (2023-2028)
        7.3.3 Europe Point-of-care Infectious Disease Diagnostics Market Share by Application (2017-2028)
    7.4 Europe Point-of-care Infectious Disease Diagnostics Market Size by Country
        7.4.1 Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2017-2022)
        7.4.2 Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size (2017-2028)
    8.2 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Type
        8.2.1 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Share by Type (2017-2028)
    8.3 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Application
        8.3.1 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Share by Application (2017-2028)
    8.4 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region
        8.4.1 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Point-of-care Infectious Disease Diagnostics Market Size (2017-2028)
    9.2 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Type
        9.2.1 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Type (2017-2022)
        9.2.2 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Type (2023-2028)
        9.2.3 Latin America Point-of-care Infectious Disease Diagnostics Market Share by Type (2017-2028)
    9.3 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Application
        9.3.1 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Application (2017-2022)
        9.3.2 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Application (2023-2028)
        9.3.3 Latin America Point-of-care Infectious Disease Diagnostics Market Share by Application (2017-2028)
    9.4 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country
        9.4.1 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2017-2022)
        9.4.2 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size (2017-2028)
    10.2 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Type
        10.2.1 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Share by Type (2017-2028)
    10.3 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Application
        10.3.1 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Share by Application (2017-2028)
    10.4 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country
        10.4.1 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Thermo Fisher Scientific
        11.1.1 Thermo Fisher Scientific Company Details
        11.1.2 Thermo Fisher Scientific Business Overview
        11.1.3 Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Introduction
        11.1.4 Thermo Fisher Scientific Revenue in Point-of-care Infectious Disease Diagnostics Business (2017-2022)
        11.1.5 Thermo Fisher Scientific Recent Developments
    11.2 Abbott
        11.2.1 Abbott Company Details
        11.2.2 Abbott Business Overview
        11.2.3 Abbott Point-of-care Infectious Disease Diagnostics Introduction
        11.2.4 Abbott Revenue in Point-of-care Infectious Disease Diagnostics Business (2017-2022)
        11.2.5 Abbott Recent Developments
    11.3 Calypte Biomedical
        11.3.1 Calypte Biomedical Company Details
        11.3.2 Calypte Biomedical Business Overview
        11.3.3 Calypte Biomedical Point-of-care Infectious Disease Diagnostics Introduction
        11.3.4 Calypte Biomedical Revenue in Point-of-care Infectious Disease Diagnostics Business (2017-2022)
        11.3.5 Calypte Biomedical Recent Developments
    11.4 Chembio Diagnostic Systems
        11.4.1 Chembio Diagnostic Systems Company Details
        11.4.2 Chembio Diagnostic Systems Business Overview
        11.4.3 Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Introduction
        11.4.4 Chembio Diagnostic Systems Revenue in Point-of-care Infectious Disease Diagnostics Business (2017-2022)
        11.4.5 Chembio Diagnostic Systems Recent Developments
    11.5 Meridian Bioscience
        11.5.1 Meridian Bioscience Company Details
        11.5.2 Meridian Bioscience Business Overview
        11.5.3 Meridian Bioscience Point-of-care Infectious Disease Diagnostics Introduction
        11.5.4 Meridian Bioscience Revenue in Point-of-care Infectious Disease Diagnostics Business (2017-2022)
        11.5.5 Meridian Bioscience Recent Developments
    11.6 MedMira
        11.6.1 MedMira Company Details
        11.6.2 MedMira Business Overview
        11.6.3 MedMira Point-of-care Infectious Disease Diagnostics Introduction
        11.6.4 MedMira Revenue in Point-of-care Infectious Disease Diagnostics Business (2017-2022)
        11.6.5 MedMira Recent Developments
    11.7 Trinity Biotech
        11.7.1 Trinity Biotech Company Details
        11.7.2 Trinity Biotech Business Overview
        11.7.3 Trinity Biotech Point-of-care Infectious Disease Diagnostics Introduction
        11.7.4 Trinity Biotech Revenue in Point-of-care Infectious Disease Diagnostics Business (2017-2022)
        11.7.5 Trinity Biotech Recent Developments
    11.8 Sekisui Diagnostics
        11.8.1 Sekisui Diagnostics Company Details
        11.8.2 Sekisui Diagnostics Business Overview
        11.8.3 Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Introduction
        11.8.4 Sekisui Diagnostics Revenue in Point-of-care Infectious Disease Diagnostics Business (2017-2022)
        11.8.5 Sekisui Diagnostics Recent Developments
    11.9 OraSure Technologies
        11.9.1 OraSure Technologies Company Details
        11.9.2 OraSure Technologies Business Overview
        11.9.3 OraSure Technologies Point-of-care Infectious Disease Diagnostics Introduction
        11.9.4 OraSure Technologies Revenue in Point-of-care Infectious Disease Diagnostics Business (2017-2022)
        11.9.5 OraSure Technologies Recent Developments
    11.10 Quidel
        11.10.1 Quidel Company Details
        11.10.2 Quidel Business Overview
        11.10.3 Quidel Point-of-care Infectious Disease Diagnostics Introduction
        11.10.4 Quidel Revenue in Point-of-care Infectious Disease Diagnostics Business (2017-2022)
        11.10.5 Quidel Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of HIV POC
    Table 3. Key Players of Clostridium Difficile POC
    Table 4. Key Players of HBV POC
    Table 5. Key Players of Respiratory Syncytial Virus POC
    Table 6. Key Players of HPV POC
    Table 7. Key Players of Influenza/Flu POC
    Table 8. Key Players of HCV POC
    Table 9. Key Players of MRSA POC
    Table 10. Key Players of TB and Drug-Resistant TB POC
    Table 11. Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 12. Global Point-of-care Infectious Disease Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 13. Global Point-of-care Infectious Disease Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 14. Global Point-of-care Infectious Disease Diagnostics Market Share by Region (2017-2022)
    Table 15. Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 16. Global Point-of-care Infectious Disease Diagnostics Market Share by Region (2023-2028)
    Table 17. Point-of-care Infectious Disease Diagnostics Market Trends
    Table 18. Point-of-care Infectious Disease Diagnostics Market Drivers
    Table 19. Point-of-care Infectious Disease Diagnostics Market Challenges
    Table 20. Point-of-care Infectious Disease Diagnostics Market Restraints
    Table 21. Global Point-of-care Infectious Disease Diagnostics Revenue by Players (2017-2022) & (US$ Million)
    Table 22. Global Point-of-care Infectious Disease Diagnostics Revenue Share by Players (2017-2022)
    Table 23. Global Top Point-of-care Infectious Disease Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Infectious Disease Diagnostics as of 2021)
    Table 24. Ranking of Global Top Point-of-care Infectious Disease Diagnostics Companies by Revenue (US$ Million) in 2021
    Table 25. Global 5 Largest Players Market Share by Point-of-care Infectious Disease Diagnostics Revenue (CR5 and HHI) & (2017-2022)
    Table 26. Key Players Headquarters and Area Served
    Table 27. Key Players Point-of-care Infectious Disease Diagnostics Product Solution and Service
    Table 28. Date of Enter into Point-of-care Infectious Disease Diagnostics Market
    Table 29. Mergers & Acquisitions, Expansion Plans
    Table 30. Global Point-of-care Infectious Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 31. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Type (2017-2022)
    Table 32. Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 33. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Type (2023-2028)
    Table 34. Global Point-of-care Infectious Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 35. Global Point-of-care Infectious Disease Diagnostics Revenue Share by Application (2017-2022)
    Table 36. Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 37. Global Point-of-care Infectious Disease Diagnostics Revenue Share by Application (2023-2028)
    Table 38. North America Point-of-care Infectious Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 39. North America Point-of-care Infectious Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 40. North America Point-of-care Infectious Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 41. North America Point-of-care Infectious Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 42. North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 43. North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Europe Point-of-care Infectious Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Europe Point-of-care Infectious Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Europe Point-of-care Infectious Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Europe Point-of-care Infectious Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 49. Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Point-of-care Infectious Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Point-of-care Infectious Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Asia Pacific Point-of-care Infectious Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Asia Pacific Point-of-care Infectious Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Asia Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 55. Asia Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2023-2028) & (US$ Million)
    Table 56. Latin America Point-of-care Infectious Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Latin America Point-of-care Infectious Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Latin America Point-of-care Infectious Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Latin America Point-of-care Infectious Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Point-of-care Infectious Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Point-of-care Infectious Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 64. Middle East and Africa Point-of-care Infectious Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 65. Middle East and Africa Point-of-care Infectious Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 66. Middle East and Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 67. Middle East and Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 68. Thermo Fisher Scientific Company Details
    Table 69. Thermo Fisher Scientific Business Overview
    Table 70. Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Product
    Table 71. Thermo Fisher Scientific Revenue in Point-of-care Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 72. Thermo Fisher Scientific Recent Developments
    Table 73. Abbott Company Details
    Table 74. Abbott Business Overview
    Table 75. Abbott Point-of-care Infectious Disease Diagnostics Product
    Table 76. Abbott Revenue in Point-of-care Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 77. Abbott Recent Developments
    Table 78. Calypte Biomedical Company Details
    Table 79. Calypte Biomedical Business Overview
    Table 80. Calypte Biomedical Point-of-care Infectious Disease Diagnostics Product
    Table 81. Calypte Biomedical Revenue in Point-of-care Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 82. Calypte Biomedical Recent Developments
    Table 83. Chembio Diagnostic Systems Company Details
    Table 84. Chembio Diagnostic Systems Business Overview
    Table 85. Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Product
    Table 86. Chembio Diagnostic Systems Revenue in Point-of-care Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 87. Chembio Diagnostic Systems Recent Developments
    Table 88. Meridian Bioscience Company Details
    Table 89. Meridian Bioscience Business Overview
    Table 90. Meridian Bioscience Point-of-care Infectious Disease Diagnostics Product
    Table 91. Meridian Bioscience Revenue in Point-of-care Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 92. Meridian Bioscience Recent Developments
    Table 93. MedMira Company Details
    Table 94. MedMira Business Overview
    Table 95. MedMira Point-of-care Infectious Disease Diagnostics Product
    Table 96. MedMira Revenue in Point-of-care Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 97. MedMira Recent Developments
    Table 98. Trinity Biotech Company Details
    Table 99. Trinity Biotech Business Overview
    Table 100. Trinity Biotech Point-of-care Infectious Disease Diagnostics Product
    Table 101. Trinity Biotech Revenue in Point-of-care Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 102. Trinity Biotech Recent Developments
    Table 103. Sekisui Diagnostics Company Details
    Table 104. Sekisui Diagnostics Business Overview
    Table 105. Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Product
    Table 106. Sekisui Diagnostics Revenue in Point-of-care Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 107. Sekisui Diagnostics Recent Developments
    Table 108. OraSure Technologies Company Details
    Table 109. OraSure Technologies Business Overview
    Table 110. OraSure Technologies Point-of-care Infectious Disease Diagnostics Product
    Table 111. OraSure Technologies Revenue in Point-of-care Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 112. OraSure Technologies Recent Developments
    Table 113. Quidel Company Details
    Table 114. Quidel Business Overview
    Table 115. Quidel Point-of-care Infectious Disease Diagnostics Product
    Table 116. Quidel Revenue in Point-of-care Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 117. Quidel Recent Developments
    Table 118. Research Programs/Design for This Report
    Table 119. Key Data Information from Secondary Sources
    Table 120. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Point-of-care Infectious Disease Diagnostics Market Share by Type: 2021 VS 2028
    Figure 2. HIV POC Features
    Figure 3. Clostridium Difficile POC Features
    Figure 4. HBV POC Features
    Figure 5. Respiratory Syncytial Virus POC Features
    Figure 6. HPV POC Features
    Figure 7. Influenza/Flu POC Features
    Figure 8. HCV POC Features
    Figure 9. MRSA POC Features
    Figure 10. TB and Drug-Resistant TB POC Features
    Figure 11. Global Point-of-care Infectious Disease Diagnostics Market Share by Application: 2021 VS 2028
    Figure 12. Hospitals Case Studies
    Figure 13. Clinics Case Studies
    Figure 14. Home Case Studies
    Figure 15. Assisted Living Healthcare Facilities Case Studies
    Figure 16. Laboratories Case Studies
    Figure 17. Others Case Studies
    Figure 18. Point-of-care Infectious Disease Diagnostics Report Years Considered
    Figure 19. Global Point-of-care Infectious Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 20. Global Point-of-care Infectious Disease Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 21. Global Point-of-care Infectious Disease Diagnostics Market Share by Region: 2021 VS 2028
    Figure 22. Global Point-of-care Infectious Disease Diagnostics Market Share by Players in 2021
    Figure 23. Global Top Point-of-care Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Infectious Disease Diagnostics as of 2021)
    Figure 24. The Top 10 and 5 Players Market Share by Point-of-care Infectious Disease Diagnostics Revenue in 2021
    Figure 25. North America Point-of-care Infectious Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 26. North America Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 27. North America Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 28. North America Point-of-care Infectious Disease Diagnostics Market Size Share by Country (2017-2028)
    Figure 29. United States Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Canada Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Europe Point-of-care Infectious Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Europe Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 33. Europe Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 34. Europe Point-of-care Infectious Disease Diagnostics Market Size Share by Country (2017-2028)
    Figure 35. Germany Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. France Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. U.K. Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Italy Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Russia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Nordic Countries Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Asia Pacific Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 43. Asia Pacific Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 44. Asia Pacific Point-of-care Infectious Disease Diagnostics Market Size Share by Region (2017-2028)
    Figure 45. China Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Japan Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. South Korea Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Southeast Asia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. India Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Australia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 51. Latin America Point-of-care Infectious Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 52. Latin America Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 53. Latin America Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 54. Latin America Point-of-care Infectious Disease Diagnostics Market Size Share by Country (2017-2028)
    Figure 55. Mexico Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Brazil Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 58. Middle East and Africa Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 59. Middle East and Africa Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 60. Middle East and Africa Point-of-care Infectious Disease Diagnostics Market Size Share by Country (2017-2028)
    Figure 61. Turkey Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 62. Saudi Arabia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 63. UAE Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 64. Thermo Fisher Scientific Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2017-2022)
    Figure 65. Abbott Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2017-2022)
    Figure 66. Calypte Biomedical Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2017-2022)
    Figure 67. Chembio Diagnostic Systems Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2017-2022)
    Figure 68. Meridian Bioscience Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2017-2022)
    Figure 69. MedMira Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2017-2022)
    Figure 70. Trinity Biotech Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2017-2022)
    Figure 71. Sekisui Diagnostics Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2017-2022)
    Figure 72. OraSure Technologies Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2017-2022)
    Figure 73. Quidel Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2017-2022)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Thermo Fisher Scientific
Abbott
Calypte Biomedical
Chembio Diagnostic Systems
Meridian Bioscience
MedMira
Trinity Biotech
Sekisui Diagnostics
OraSure Technologies
Quidel
Frequently Asked Questions
Point-of-care Infectious Disease Diagnostics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Point-of-care Infectious Disease Diagnostics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Point-of-care Infectious Disease Diagnostics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Polyamideimide

Polyamideimide market is segmented by Type and by Application. Players, stakeholders, and other p ... Read More